Sahin Ugur's Form 4 filing
BioNTech SE (BNTX) · filed Sep 30, 2026
- Accession no.
- 0002123975-26-000027
- Filed
- Sep 30, 2026, 4:29 PM ET
- Trade date
- Sep 29-30, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $6.48M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sahin UgurCIK 0002123975 | Officer (Chief Executive Officer), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 29, 2026 | Ordinary Shares | SSaleDisposed | −34,000 | $98.26 | −$3,340,809.4 | 246,209 | Direct | |
| Sep 30, 2026 | Ordinary Shares | SSaleDisposed | −32,000 | $98.12 | −$3,139,849.6 | 214,209 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on June 3, 2026.